Cargando…
Does massively parallel transcriptome analysis signify the end of cancer histopathology as we know it?
Transcriptional analysis of all the genes expressed by breast tumors has provided the first steps towards defining a molecular signature for the disease, and might ultimately make conventional diagnostic techniques obsolete.
Autores principales: | Aparicio, Samuel AJR, Caldas, Carlos, Ponder, Bruce |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138863/ https://www.ncbi.nlm.nih.gov/pubmed/11178245 |
Ejemplares similares
-
Assessing the prognosis of cirrhotic patients in the intensive care unit: What we know and what we need to know better
por: da Silveira, Fernando, et al.
Publicado: (2021) -
What We Know Currently about Mirror Neurons
por: Kilner, J.M., et al.
Publicado: (2013) -
Immunity to SARS-CoV-2: What Do We Know and Should We Be Testing for It?
por: Misra, Anisha, et al.
Publicado: (2022) -
Histopathological assessment of the microscopic activity in inflammatory bowel diseases: What are we looking for?
por: Fabian, Ondrej, et al.
Publicado: (2022) -
Association between acute pancreatitis and COVID-19 infection: What do we know?
por: Jabłońska, Beata, et al.
Publicado: (2021)